RIGEL PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $40.4M | $131.7M | $43.5M |
| FY2016 | $23.1M | $78.1M | $17.6M |
| FY2017 | $18.5M | $119.1M | $38.3M |
| FY2018 | $29.2M | $139.1M | $76.3M |
| FY2019 | $93.8M | $147.6M | $22.5M |
| FY2020 | $76.4M | $110.4M | $30.4M |
| FY2021 | $137.0M | $167.3M | $18.9M |
| FY2022 | $147.9M | $134.3M | $24.5M |
| FY2023 | $145.9M | $117.2M | $32.8M |
| FY2024 | $160.7M | $164.0M | $56.7M |